{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:01:08Z","timestamp":1790107268110,"version":"4.0.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-fusion associated renal cell carcinoma (<jats:italic toggle=\"yes\">TFE3<\/jats:italic>-RCC) accounts for up to 5% adults and 40% of childhood RCC. Their comprehensive immunohistochemical (IHC) profile in correlation to fluorescence in situ hybridization (FISH) testing and their role in the diagnostic approach are not well documented because of lacking published data. FISH confirmed <jats:italic toggle=\"yes\">TFE3-<\/jats:italic>RCC between years 2010 and 2020 were identified from institutional electronic database and retrospectively reviewed. Eighty-five <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-RCC were identified. Seventy-six of 85 (89.4%) <jats:italic toggle=\"yes\">TFE3-<\/jats:italic>RCC cases had positive <jats:italic toggle=\"yes\">TFE3<\/jats:italic> expression, with diffuse and strong\/moderate <jats:italic toggle=\"yes\">TFE3<\/jats:italic> expression in 45 (54.2%). Three (3.5%) <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-RCC had negative <jats:italic toggle=\"yes\">TFE3<\/jats:italic> expression whereas 6 (7%) cases had equivocal <jats:italic toggle=\"yes\">TFE3<\/jats:italic> expression. On the other hand, positive <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-IHC expression was observed in 17\/29 (58.6%) <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-FISH negative RCC cases, although only 8 (27.5%) had diffuse and moderate\/strong <jats:italic toggle=\"yes\">TFE3<\/jats:italic> expression. Diffuse and strong <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-IHC expression was statistically significant in predicting <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-FISH positivity (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001) regardless of morphologic features. After univariate and multivariate analyses, <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-IHC was the only parameter with significant predictive value for detecting positive <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-FISH (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). On univariate analysis, sex, classic morphology, age, negative AE1\/AE3 or cytokeratin 7 were not predictive of <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-FISH positivity. Diffuse and strong nuclear <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-IHC expression is significantly associated with <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-FISH positivity and can be used as a surrogate marker to confirm translocation associated cases. <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-rearranged RCCs show variable histomorphologic features and <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-FISH should be performed in cases presenting at a younger age or, regardless of the age, tumors with unusual morphology. Despite previous reports, negative pancytokeratin and positive cathepsin K expression may not be reliable markers for <jats:italic toggle=\"yes\">TFE3<\/jats:italic>-RCC.<\/jats:p>","DOI":"10.1097\/pas.0000000000001541","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T07:49:17Z","timestamp":1595490557000},"page":"1450-1458","source":"Crossref","is-referenced-by-count":24,"title":["Morphologic and Immunohistochemical Characteristics of Fluorescent In Situ Hybridization Confirmed TFE3-Gene Fusion Associated Renal Cell Carcinoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Mahmut","family":"Akgul","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Saeed","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Levy","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Mann","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Urology, Indiana University, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Grignon","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Eble","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad T.","family":"Idrees","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1158\/1078-0432.CCR-08-1183","article-title":"Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry","volume":"15","author":"Komai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/PAS.0b013e31824f24a6","article-title":"Translocation renal cell carcinomas in adults: a single-institution experience","volume":"36","author":"Zhong","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/PAS.0b013e3181dd577e","article-title":"Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma","volume":"34","author":"Zhong","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0165-4608(86)90042-7","article-title":"Cytogenetics of a renal adenocarcinoma in a 2-year-old child","volume":"21","author":"De Jong","year":"1986","journal-title":"Cancer Genet Cytogenet"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-4608(93)90050-V","article-title":"Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype","volume":"65","author":"Meloni","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.semdp.2015.02.003","article-title":"MiT family translocation renal cell carcinoma","volume":"32","author":"Argani","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/hmg\/5.9.1333","article-title":"The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene","volume":"5","author":"Sidhar","year":"1996","journal-title":"Hum Mol Genet"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/sj.onc.1201394","article-title":"Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma","volume":"15","author":"Clark","year":"1997","journal-title":"Oncogene"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000927","article-title":"Melanotic translocation renal cell carcinoma with a novel ARID1B-TFE3 gene fusion","volume":"41","author":"Antic","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"RBM10-TFE3 renal cell carcinoma: a potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00428-018-2509-8","article-title":"A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion","volume":"474","author":"Fukuda","year":"2019","journal-title":"Virchows Archiv"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41379-018-0191-7","article-title":"NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma","volume":"32","author":"Pei","year":"2019","journal-title":"Mod Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"5974089","DOI":"10.1155\/2019\/5974089","article-title":"A rare partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of MED15-TFE3 fusion","volume":"2019","author":"Ye","year":"2019","journal-title":"Biomed Res Int"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrurol.2014.162","article-title":"Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers","volume":"11","author":"Kauffman","year":"2014","journal-title":"Nat Rev Urol"},{"key":"R16-20230922","first-page":"327","article-title":"Xp11.2 translocation\/TFE3 gene fusion renal cell carcinoma with a micropapillary pattern: cases report and literature review","volume":"11","author":"Xu","year":"2019","journal-title":"Am J Transl Res"},{"key":"R17-20230922","first-page":"125","article-title":"MiT family translocation renal cell carcinomas: a 15th anniversary update","volume":"35","author":"Gandhi","year":"2020","journal-title":"Histol Histopathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/PAS.0000000000000258","article-title":"Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Reuter","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"A distinctive subset of PEComas harbors TFE3 gene fusions","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.prp.2016.07.004","article-title":"TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation","volume":"212","author":"Thorner","year":"2016","journal-title":"Pathol Res Pract"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41379-019-0283-z","article-title":"Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis","volume":"32","author":"Yang","year":"2019","journal-title":"Mod Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R25-20230922","first-page":"6355","article-title":"Granular cell tumors overexpress TFE3 without gene rearrangement: evaluation of immunohistochemistry and break-apart FISH in 45 cases","volume":"18","author":"Liu","year":"2019","journal-title":"Oncol Lett"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13000-019-0814-4","article-title":"Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis","volume":"14","author":"Zhou","year":"2019","journal-title":"Diagn Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2019.02.008","article-title":"Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study","volume":"87","author":"Sharain","year":"2019","journal-title":"Hum Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/PAS.0b013e31828a69ae","article-title":"Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service","volume":"37","author":"Green","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","article-title":"Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/modpathol.2013.208","article-title":"Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage","volume":"27","author":"Ellis","year":"2014","journal-title":"Mod Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0b013e3181609914","article-title":"Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature","volume":"32","author":"Camparo","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/his.13735","article-title":"Grading of renal cell carcinoma","volume":"74","author":"Delahunt","year":"2019","journal-title":"Histopathology"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/00000478-200212000-00003","article-title":"PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21)","volume":"26","author":"Argani","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2016.204","article-title":"Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement","volume":"30","author":"Xia","year":"2017","journal-title":"Mod Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000776","article-title":"Renal cell carcinoma with chromosome 6p amplification including the TFEB gene: a novel mechanism of tumor pathogenesis?","volume":"41","author":"Williamson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0002-9440(10)64680-9","article-title":"A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation","volume":"158","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/his.13727","article-title":"New and emerging renal entities: a perspective post-WHO 2016 classification","volume":"74","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/modpathol.2009.58","article-title":"Cathepsin-K immunoreactivity distinguishes MiTF\/TFE family renal translocation carcinomas from other renal carcinomas","volume":"22","author":"Martignoni","year":"2009","journal-title":"Mod Pathol"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.5858\/arpa.2013-0653-RA","article-title":"Diagnostic approach to eosinophilic renal neoplasms","volume":"138","author":"Kryvenko","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5858\/2010-0478-RAR.1","article-title":"Immunohistochemical diagnosis of renal neoplasms","volume":"135","author":"Truong","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PDM.0b013e31820e9c67","article-title":"Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas","volume":"20","author":"Mosquera","year":"2011","journal-title":"Diagn Mol Pathol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13000-015-0412-z","article-title":"Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma","volume":"10","author":"Pradhan","year":"2015","journal-title":"Diagn Pathol"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/his.13866","article-title":"RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review","volume":"75","author":"Kato","year":"2019","journal-title":"Histopathology"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gcc.22801","article-title":"A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor","volume":"59","author":"Argani","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/his.13167","article-title":"Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas","volume":"70","author":"Classe","year":"2017","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:55:50Z","timestamp":1695423350000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001541"}},"subtitle":["A Single Institutional Cohort"],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001541","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,21]]}}}